The Impact of COVID-19 is included in Uterine Cancer Diagnostics Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Uterine Cancer Diagnostics Trends and Forecast
The future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement in uterine cancer diagnostics, and the growing prevalence of obesity among women worldwide.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Uterine Cancer Diagnostics by Segment
The study includes a forecast for the global uterine cancer diagnostics by diagnostic type, type, age group, end use, and region.
Uterine Cancer Diagnostics Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:
• Instrument Based
• Procedure Based
Uterine Cancer Diagnostics Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Endometrial Cancer
• Uterine Sarcoma
Uterine Cancer Diagnostics Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:
• <30
• 31-40
• 41-50
• 51-60
• >60
Uterine Cancer Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Diagnostic Centers
• Cancer Research Center
• Others
Uterine Cancer Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Uterine Cancer Diagnostics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies uterine cancer diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the uterine cancer diagnostics companies profiled in this report include-
• Siemens Healthcare
• Narang Medical
• F-Hoffmann La Roche
• Esaote
• Samsung Medison
• Olympus
• Arquer Diagnostics
• Guzip Biomarkers
• General Electric
• Canon Medical
Uterine Cancer Diagnostics Market Insights
Lucintel forecasts that instrument based is expected to witness higher growth over the forecast period due to evolution of diagnostic imaging technology, resulting in heightened precision.
Within this market, hospitals will remain the largest segment due to increasing prevelance of cancer cases, growing demand for minimally invasive advanced screening techniques, and rising investments and funding in cancer daignostics in hospitals.
North America will remain the largest region over the forecast period due to growing incidence rate of uterine cancer in the US, emphasizing the significance of timely detection and preventive measures to combat cancer, and increasing number of various cancer awareness programs by the government.
Features of the Global Uterine Cancer Diagnostics Market
Market Size Estimates: Uterine cancer diagnostics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Uterine cancer diagnostics market size by various segments, such as by diagnostic type, type, age group, end use, and region in terms of ($B).
Regional Analysis: Uterine cancer diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different diagnostic types, types, age groups, end uses, and regions for the uterine cancer diagnostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the uterine cancer diagnostics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the uterine cancer diagnostics market size?
Answer: The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030.
Q.2 What is the growth forecast for uterine cancer diagnostics market?
Answer: The global uterine cancer diagnostics market is expected to grow with a CAGR of 9.0% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the uterine cancer diagnostics market?
Answer: The major drivers for this market are the increasing cases of uterine cancer, technological advancement in uterine cancer diagnostics and the growing prevalence of obesity among women worldwide.
Q4. What are the major segments for uterine cancer diagnostics market?
Answer: The future of the uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets.
Q5. Who are the key uterine cancer diagnostics market companies?
Answer: Some of the key uterine cancer diagnostics companies are as follows:
• Siemens Healthcare
• Narang Medical
• F-Hoffmann La Roche
• Esaote
• Samsung Medison
• Olympus
• Arquer Diagnostics
• Guzip Biomarkers
• General Electric
• Canon Medical
Q6. Which uterine cancer diagnostics market segment will be the largest in future?
Answer: Lucintel forecasts that instrument based is expected to witness higher growth over the forecast period due to evolution of diagnostic imaging technology, resulting in heightened precision.
Q7. In uterine cancer diagnostics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing incidence rate of uterine cancer in the US, emphasizing the significance of timely detection and preventive measures to combat cancer, and increasing number of various cancer awareness programs by the government.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the uterine cancer diagnostics market by diagnostic type (instrument based and procedure based), type (endometrial cancer and uterine sarcoma), age group (<30, 31-40, 41-50, 51-60 , and >60), end use (hospitals, diagnostic centers, cancer research center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Uterine Cancer Diagnostics Market, Uterine Cancer Diagnostics Market Size, Uterine Cancer Diagnostics Market Growth, Uterine Cancer Diagnostics Market Analysis, Uterine Cancer Diagnostics Market Report, Uterine Cancer Diagnostics Market Share, Uterine Cancer Diagnostics Market Trends, Uterine Cancer Diagnostics Market Forecast, Uterine Cancer Diagnostics Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Uterine Cancer Diagnostics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Uterine Cancer Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Uterine Cancer Diagnostics Market by Diagnostic Type
3.3.1: Instrument Based
3.3.2: Procedure Based
3.4: Global Uterine Cancer Diagnostics Market by Type
3.4.1: Endometrial Cancer
3.4.2: Uterine Sarcoma
3.5: Global Uterine Cancer Diagnostics Market by Age Group
3.5.1: <30
3.5.2: 31-40
3.5.3: 41-50
3.5.4: 51-60
3.5.5: >60
3.6: Global Uterine Cancer Diagnostics Market by End Use
3.6.1: Hospitals
3.6.2: Diagnostic Centers
3.6.3: Cancer Research Center
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Uterine Cancer Diagnostics Market by Region
4.2: North American Uterine Cancer Diagnostics Market
4.2.2: North American Uterine Cancer Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Center, and Others
4.3: European Uterine Cancer Diagnostics Market
4.3.1: European Uterine Cancer Diagnostics Market by Diagnostic Type: Instrument Based and Procedure Based
4.3.2: European Uterine Cancer Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Center, and Others
4.4: APAC Uterine Cancer Diagnostics Market
4.4.1: APAC Uterine Cancer Diagnostics Market by Diagnostic Type: Instrument Based and Procedure Based
4.4.2: APAC Uterine Cancer Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Center, and Others
4.5: ROW Uterine Cancer Diagnostics Market
4.5.1: ROW Uterine Cancer Diagnostics Market by Diagnostic Type: Instrument Based and Procedure Based
4.5.2: ROW Uterine Cancer Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Center, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Uterine Cancer Diagnostics Market by Diagnostic Type
6.1.2: Growth Opportunities for the Global Uterine Cancer Diagnostics Market by Type
6.1.3: Growth Opportunities for the Global Uterine Cancer Diagnostics Market by Age Group
6.1.4: Growth Opportunities for the Global Uterine Cancer Diagnostics Market by End Use
6.1.5: Growth Opportunities for the Global Uterine Cancer Diagnostics Market by Region
6.2: Emerging Trends in the Global Uterine Cancer Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Uterine Cancer Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Uterine Cancer Diagnostics Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Siemens Healthcare
7.2: Narang Medical
7.3: F-Hoffmann La Roche
7.4: ESAOTE
7.5: Samsung Medison
7.6: Olympus
7.7: Arquer Diagnostics
7.8: Guzip Biomarkers
7.9: General Electric
7.10: Canon Medical
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Uterine Cancer Diagnostics Market Report.